Other studies in breast cancer have shown that mir-106b/25 cluster activates TGF-β signaling and epithelial-mesenchymal transition (EMT) (17) and miR-221/222 cluster is a key regulator of luminal breast cancer tumor progression (18). This evidence concerns the gene TGFB1 and breast carcinoma.